Back to today’s briefing

Story perspectives

Boson Ventures Secures $300K Grant to Link Australia-China Biotech

8/1/2025

50 11

Summary

Story summary

Boson Ventures, based in Melbourne, connects Australian biotech startups with China's expanding pharmaceutical market.
The firm secured a $300,000 grant from LaunchVic to boost operations in Victoria.
China's investment in R&D has increased from 0.9% to 2.7% of GDP over the past 20 years.
In 2021, China outpaced the U.S. in total clinical trials and continues to grow its lead.

1 of 1

Story summary

Boson Ventures, based in Melbourne, connects Australian biotech startups with China's expanding pharmaceutical market.
The firm secured a $300,000 grant from LaunchVic to boost operations in Victoria.
China's investment in R&D has increased from 0.9% to 2.7% of GDP over the past 20 years.
In 2021, China outpaced the U.S. in total clinical trials and continues to grow its lead.